悦康药业集团股份有限公司关于向香港联交所递交H股发行上市申请并刊发申请资料的公告

Core Viewpoint - Yuyuan Pharmaceutical Group Co., Ltd. has submitted an application for the issuance of H-shares and listing on the Hong Kong Stock Exchange, with the application materials published on the exchange's website [1][2]. Group 1 - The company submitted the application for H-share issuance and listing on December 29, 2025, and published the application materials on the Hong Kong Stock Exchange website [1]. - The application is intended for overseas investors and qualified domestic investors under Chinese laws, and will not be published on domestic exchanges [2]. - The issuance and listing are subject to approval from various regulatory bodies, including the China Securities Regulatory Commission and the Hong Kong Securities and Futures Commission, indicating potential uncertainties [3].